Syngulon
Pre-clinicalgenetic security, contamination prevention, genetic safety, yield increase
Founded
2013
Focus
Synthetic BiologyMicrobiome
About
genetic security, contamination prevention, genetic safety, yield increase
Funding History
2Total raised: $4.7M
Series A$3.5MNoshaqNov 15, 2022
Seed$1.2MWallonie EntreprendreMar 15, 2020
Company Info
TypePrivate
Founded2013
LocationGosselies, Belgium
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile